中药复方抗肺纤维化机制研究  

Mechanism research of Chinese medicine Fufang for treatment of pulmonary fibrosis

作　　者：杨光[1] 宫晓燕[2] 张海洋[2] 汪涵源[3] 

机构地区：[1]吉林大学第二医院在中医科,长春130041 [2]长春中医药大学,长春130117 [3]长春市宽城区中医院,长春130051

出　　处：《吉林中医药》2014年第4期430-432,共3页Jilin Journal of Chinese Medicine

基　　金：吉林省科技厅自然基金(201015206)

摘　　要：肺纤维化是一种较为严重的慢性肺间质性疾病,其发病机制与细胞因子紊乱有关,病变部位主要在肺间质、肺泡和(或)细支气管,临床上多以活动后呼吸困难、限制性通气功能障碍、动脉氧分差增大、弥散功能降低、低氧血症为主要特征;糖皮质激素和免疫抑制药是传统治疗肺纤维化的药物。目前,应用中医药复方治疗肺纤维化,可有助于改善临床患者生活质量。Pulmonary fibrosis（ PF） is a severe chronic interstitium disease in the lung,The occurrence of pulmonary fibrosis associated with cytokines disorder,The lesions mainly in interstitial lung,alveolar and bronchiolar,Clinically with dyspnea after activity,restrictive ventilation dysfunction,arterial oxygen difference increases,diffusion function decrease,hypoxemia as main features,Corticosteroids and immunosuppressive drugs is the traditional drug treatment of pulmonary fibrosis; Chinese Medicine Fufang have increasing shown their obvious advantages,Combination of traditional Chinese medicine was applied to the treatment of pulmonary fibrosis,help to improve the clinical patients quality of life.

关 键 词：肺纤维化 机制 细胞因子 限制性通气功能障碍 综述 

分 类 号：R318[医药卫生—生物医学工程]